参考文献/References:
［1］徐国厚，黄海峡，陈斌，等.单体检中心23695例体检者首次胸部低剂量CT筛查结果及肺结节相关易感因素的研究［J］.复旦学报（医学版），2020，47：654-659，668.
［2］叶欣，王俊，危志刚，等.热消融治疗肺部亚实性结节专家共识（2021年版）［J］.中国肺癌杂志，2021，24：305-322.
［3］Fan L，Wang Y，Zhou Y，et al. Lung cancer screening with low-dose CT：baseline screening results in Shanghai［J］. Acad Radiol，2019，26：1283-1291.
［4］He YT，Zhang YC，Shi GF，et al. Risk factors for pulmonary nodules in North China：a prospective cohort study［J］. Lung Cancer，2018，120：122-129.
［5］Loverdos K，Fotiadis A，Kontogianni C，et al. Lung nodules：a comprehensive review on current approach and management［J］. Ann Thorac Med，2019，14：226-238.
［6］Felix L，Serra-Tosio G，Lantuejoul S，et al. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme［J］. Eur J Radiol，2011，77：410-416.
［7］Succony L，Rassl DM，Barker AP，et al. Adenocarcinoma spectrum lesions of the lung：detection，pathology and treatment strategies［J］. Cancer Treat Rev，2021，99：102237.
［8］Gould MK，Donington J，Lynch WR，et al. Evaluation of individuals with pulmonary nodules：when is it lung cancer? Diagnosis and management of lung cancer，3rd ed：American College of Chest Physicians evidence-based clinical practice guidelines［J］. Chest，2013，143：e93S-e120S.
［9］MacMahon H，Naidich DP，Goo JM，et al. Guidelines for management of incidental pulmonary nodules detected on CT images：from the fleischner society 2017［J］. Radiology，2017，284：228-243.
［10］Shimada Y，Saji H，Otani K，et al. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities，and the management of their residual lesions［J］. Lung Cancer，2015，88：174-180.
［11］Sato Y，Fujimoto D，Morimoto T，et al. Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity［J］. Respirology，2017，22：1615-1621.
［12］Hattori A，Takamochi K，Oh S，et al. Prognostic classification of multiple primary lung cancers based on aground-glass opacity component［J］. Ann Thorac Surg，2020，109：420-427.
［13］Hattori A，Matsunaga T，Takamochi K，et al. Surgical management of multifocal ground-glass opacities of the lung：correlation of clinicopathologic and radiologic findings［J］. Thorac Cardiovasc Surg，2017，65：142-149.
［14］Gu B，Burt BM，Merritt RE，et al. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease［J］. Ann Thorac Surg，2013，96：411-418.
［15］张亚锋，夏晓明.微创肺段切除术与肺楔形切除术治疗以肺磨玻璃结节为表现形式的肺原位腺癌的临床研究与分析［J］.山西医药杂志，2023，52：112-115.
［16］韩连奎，高树庚，谭锋维，等.同时性多原发肺癌的诊治体会及处理策略新进展［J］.中国肺癌杂志，2018，21：180-184.
［17］姜格宁，陈昶，朱余明，等.上海市肺科医院磨玻璃结节早期肺腺癌的诊疗共识（第一版）［J］.中国肺癌杂志，2018，21：147-159.
［18］Chiang CL，Tsai PC，Yeh YC，et al. Recent advances in the diagnosis and management of multiple primary lung cancer［J］. Cancers（Basel），2022，14：242.
［19］Watanabe T，Tanahashi M，Suzuki E，et al. Surgical treatment for synchronous multiple primary lung cancer：is it possible to achieve both curability and preservation of the pulmonary function?［J］. Thorac Cancer，2021，12：2996-3004.
［20］Liu M，He W，Yang J，et al. Surgical treatment of synchronous multiple primary lung cancers：a retrospective analysis of 122 patients［J］. J Thorac Dis，2016，8：1197-1204.
［21］Ye T，Deng L，Wang S，et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype［J］. J Thorac Oncol，2019，14：617-627.
［22］Zhang Y，Fu F，Wen Z，et al. Segment location and ground glass opacity ratio reliably predict node-negative status in lung cancer［J］. Ann Thorac Surg，2020，109：1061-1068.
［23］Sato M，Yang SM，Tian D，et al. Managing screening-detected subsolid nodules-the Asian perspective［J］. Transl Lung Cancer Res，2021，10：2323-2334.
［24］Onishi H，Shioyama Y，Matsumoto Y，et al. Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity［J］. J Radiat Res，2020，61：426-430.
［25］Kann BH，Verma V，Stahl JM，et al. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma［J］. Radiother Oncol，2019，134：44-49.
［26］de Baere T，Tselikas L，Catena V，et al. Percutaneous thermal ablation of primary lung cancer［J］. Diagn Interv Imaging，2016，97：1019-1024.
［27］Hess A，Palussiere J，Goyers JF，et al. Pulmonary radiofrequency ablation in patients with a single lung：feasibility，efficacy，and tolerance［J］. Radiology，2011，258：635-642.
［28］Lin M，Eiken P，Blackmon S. Image guided thermal ablation in lung cancer treatment［J］. J Thorac Dis，2020，12：7039-7047.
［29］Howington JA，Blum MG，Chang AC，et al. Treatment of stage Ⅰ and Ⅱ non-small cell lung cancer：diagnosis and management of lung cancer，3rd ed：American College of Chest Physicians evidence-based clinical practice guidelines［J］. Chest，2013，143：e278S-e313S.
［30］Kodama H，Yamakado K，Hasegawa T，et al. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma［J］. J Vasc Interv Radiol，2014，25：333-339.
［31］罗君，邵国良，郑家平，等.CT引导下射频消融治疗33例肺癌的回顾性分析［J］.介入放射学杂志，2015，24：530-533.
［32］Dupuy DE，Fernando HC，Hillman S，et al. Radiofrequency ablation of stage ⅠA non-small cell lung cancer in medically inoperable patients：results from the American College of Surgeons Oncology Group Z4033（Alliance）trial［J］. Cancer，2015，121：3491-3498.
［33］Lam A，Yoshida EJ，Bui K，et al. A National cancer database analysis of radiofrequency ablation versus stereotactic body radiotherapy inearly-stage non-small cell lung cancer［J］. J Vasc Interv Radiol，2018，29：1211-1217.e1.
［34］Huang G，Yang X，Li W，et al. A feasibility and safety study of computed tomography-guided percutaneous microwave ablation：a novel therapy for multiple synchronous ground-glass opacities of the lung［J］. Int J Hyperthermia，2020，37：414-422.
［35］韩晓颖，杨霞，叶欣，等.CT导引微波消融治疗高龄老人早期周围型非小细胞肺癌32例［J］.介入放射学杂志，2018，27：1051-1055.
［36］Liu B，Zhang Y，Su L，et al. Treatment options for pulmonary multifocal ground glass opacity type adenocarcinoma：surgery combine thermal ablation?［J］. J Interv Med，2020，3：180-183.
［37］侯立泳，高兴强，王永，等.经皮微波消融与胸腔镜肺叶切除术治疗Ⅰ期非小细胞肺癌的疗效［J］.介入放射学杂志，2019，28：851-854.
［38］Allaf ME，Varkarakis IM，Bhayani SB，et al. Pain control requirements for percutaneous ablation of renal tumors：cryoablation versus radiofrequency ablation：initial observations［J］. Radiology，2005，237：366-370.
［39］Kim KY，Jin GY，Han YM，et al. Cryoablation of a small pulmonary nodule with pure ground-glass opacity：a case report［J］. Korean J Radiol，2015，16：657-661.
［40］李向阳，穆峰，陈继冰，等.CT引导下经皮冷冻消融治疗肺磨玻璃结节的研究［J］.介入放射学杂志，2021，30：1072-1076.
［41］Jiang B，Mcclure MA，Chen T，et al. Efficacy and safety of thermal ablation of lung malignancies：a network meta-analysis［J］. Ann Thorac Med，2018，13：243-250.
［42］高梦宇，周志刚，王猛，等.射频消融和氩氦刀冷冻消融治疗Ⅰ期非小细胞肺癌的安全性和疗效对比研究［J］.介入放射学杂志，2021，30：1010-1014.
［43］Zhao Q，Tian G，Chen F，et al. CT-guided percutaneous laser ablation of metastatic lung cancer：three cases report and literature review［J］. Oncotarget，2017，8：2187-2196.
［44］Grapatsas K，Papaporfyriou A，Leivaditis V，et al. Lung metastatectomy：canlaser-assisted surgery make a difference?［J］. Curr Oncol，2022，29：6968-6981.
［45］刘春苹，叶萍，张明悦.不可逆电穿孔对肿瘤消融的研究进展［J］.介入放射学杂志，2023，32：498-502.
相似文献/References:
[1]明建中,孙冰,曾志斌,等.外科手术后假性动脉瘤的介入治疗[J].介入放射学杂志,2010,(02):132.
MING Jianzhong,SUN Bing,ZENG Zhibin,et al.Interventional therapy of pseudoaneurysms occurred after surgery[J].journal interventional radiology,2010,(09):132.
[2]许彪,文斌,刘惕生,等.介入联合手术治疗浸润性膀胱癌[J].介入放射学杂志,2007,(01):35.
XU Biao,WEN Bin,LIU Ti-sheng,et al.Curative effect analysis of invasive bladder cancer by joint surgical operation with interventional therapy[J].journal interventional radiology,2007,(09):35.
[3]胡庭杨,俞文强,毛颖民,等.消化道大出血外科术前介入治疗的策略和临床价值[J].介入放射学杂志,2009,(12):936.
HU Tingyang,YU Wenqiang,MAO Yingmin,et al.Strategy and clinical significance of interventional management before surgical therapy for massive hemorrhage of gastrointestinal tract[J].journal interventional radiology,2009,(09):936.